Stifel Virtual Ophthalmology Forum — May 26

Stifel’s virtual ophthalmology forum is set for Tuesday, May 26, 2026, and a string of eye-care companies have used recent investor-relations announcements to flag their participation ahead of the event. The forum appears to be a one-day online meeting series for public-company executives and investors, with companies disclosing separate presentation times, webcast details and, in some cases, invitation-only meeting formats. Glaukos, STAAR Surgical, Sight Sciences, Ocular Therapeutix and RxSight are among the companies that have published notices tied to the event. Business Wire’s trade-show page carries listings for conference-related announcements, while companies are directing investors to their own sites for live and archived webcasts. ### Which companies have confirmed they will appear on May 26? Glaukos said on May 12 that its management is scheduled to participate in the “Stifel Virtual Ophthalmology Forum” on Tuesday, May 26, 2026, at 1:30 p.m. ET. The Aliso Viejo, California-based company described itself as an ophthalmic pharmaceutical and medical technology company focused on glaucoma, corneal disorders and retinal diseases. (businesswire.com) STAAR Surgical said on May 21 that its management will participate in the “Stifel 2026 Virtual Ophthalmology Forum” on the same date in a format that includes meetings and a webcast fireside chat. The Lake Forest, California-based company said investor meeting participation is by invitation only from the sponsoring brokerage firm and listed its webcast for 4:30 p.m. ET. (businesswire.com) Sight Sciences said on April 29 that it plans to present at the Stifel 2026 Virtual Ophthalmology Forum at 9:00 a.m. PT, or 12:00 p.m. ET. The Menlo Park, California-based company said interested parties can access a live and archived webcast on the investors section of its website. ### What does the schedule look like so far? Sight Sciences disclosed the earliest specific start time among the notices reviewed, with a noon ET session on May 26. (businesswire.com) RxSight said management is scheduled for a fireside chat at 10:00 a.m. Pacific Time, which is 1:00 p.m. ET, and Glaukos listed a 1:30 p.m. ET appearance. Ocular Therapeutix said its fireside chat will run from 2:30 p.m. to 2:55 p.m. EDT, and STAAR Surgical listed a 4:30 p.m. ET webcast. (sightsciences.com) Ocular Therapeutix said Pravin U. Dugel, its executive chairman, president and chief executive officer, will present for the company. The company included the Stifel session in a broader May conference schedule that also covered scientific meetings and other investor events. ### Is this an open webcast event or an invitation-only investor meeting? (sightsciences.com) STAAR Surgical said the forum will include meetings and a webcast fireside chat, but added that investor meeting participation is by invitation only from the sponsoring brokerage firm. That suggests at least part of the event is structured as broker-arranged one-on-one or small-group meetings rather than a fully open public webcast. (markets.businessinsider.com) Glaukos, Sight Sciences, Ocular Therapeutix and RxSight each said live and archived webcasts for their appearances will be available through their investor-relations websites. Those company notices did not describe the underlying Stifel meeting schedule in broader detail, but they did point investors to public webcast access for their own sessions. (businesswire.com) ### Why are these companies using the forum to speak with investors now? The participating companies span several corners of ophthalmology. Glaukos said it is focused on glaucoma, corneal disorders and retinal diseases; Sight Sciences highlighted glaucoma and dry-eye products; STAAR Surgical pointed to its EVO implantable collamer lens franchise; and RxSight described its adjustable intraocular lens system for cataract patients. (businesswire.com) Ocular Therapeutix tied its May investor appearances to recent retina data and conference presentations, including Phase 3 SOL-1 trial results for OTX-TKI in neovascular age-related macular degeneration that it said were presented at ARVO 2026. The company’s Stifel appearance comes after those May scientific updates. ### Where can investors follow the sessions? (businesswire.com) Business Wire’s trade-show subject page lists conference-related press releases, including event notices that point readers to company-specific webcast details. The page serves as a directory for announcements rather than a single public event program. Company investor-relations pages are the practical access points named in the announcements. Glaukos said webcasts will be in the investors section of its website, Sight Sciences said a live and archived webcast will be on its investors page, Ocular Therapeutix said webcasts can be accessed through its events and presentations page, RxSight said a live and archived webcast will be on its investor-relations site, and STAAR Surgical said live and archived webcasts will be available on its investor website. (businesswire.com) (markets.businessinsider.com) Tuesday, May 26, 2026, is the next concrete milestone. The published company schedules point to sessions beginning at 12:00 p.m. ET with Sight Sciences, 1:00 p.m. ET with RxSight, 1:30 p.m. ET with Glaukos, 2:30 p.m. EDT with Ocular Therapeutix and 4:30 p.m. ET with STAAR Surgical, with replays available afterward on the companies’ investor websites where applicable. (sightsciences.com) (businesswire.com)